Circulating lipopolysaccharide and zonulin (a marker of intestinal permeability) levels were shown to be significantly increased in patients with T2DM and were associated with inflammatory markers such as TNF-α, IL-6, and poor glycemic/lipid control. This evidence concerns the gene HP and type 2 diabetes mellitus.